Skip to main content

TDb SPLIT CORP. Financial Results to May 31, 2026

TORONTO, July 21, 2026 (GLOBE NEWSWIRE) — TDb Split Corp. (“the Company”) announces that its semi-annual financial statements and management report of fund performance for the six months ended May 31, 2026 are now available on the Company’s website at www.tdbsplit.com and at www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.tdbsplit.com.       Investor Relations: 1-877-478-2372 Local: 416-304-4443 www.tdbsplit.com info@quadravest.com       

Continue reading

Prime Dividend Corp. Financial Results to May 31, 2026

TORONTO, July 21, 2026 (GLOBE NEWSWIRE) — Prime Dividend Corp. (“the Company”) announces that its semi-annual financial statements and management report of fund performance for the six months ended May 31, 2026 are now available on the Company’s website at www.primedividend.com and at www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.primedividend.com.

Continue reading

Dividend 15 Split Corp. Financial Results to May 31, 2026

TORONTO, July 21, 2026 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (“the Company”) announces that its semi-annual financial statements and management report of fund performance for the six months ended May 31, 2026 are now available on the Company’s website at www.dividend15.com and at www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.dividend15.com.Investor Relations: 1-877-478-2372 Local: 416-304-4443 http://www.dividend15.com/ info@quadravest.com

Continue reading

FINANCIAL 15 SPLIT CORP. Financial Results to May 31, 2026

TORONTO, July 21, 2026 (GLOBE NEWSWIRE) — Financial 15 Split Corp. (“the Company”) announces that its semi-annual financial statements and management report of fund performance for the six months ended May 31, 2026 are now available on the Company’s website at www.financial15.com and at www.sedarplus.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.financial15.com.       Investor Relations: 1-877-478-2372 Local: 416-304-4443 www.financial15.com info@quadravest.com        

Continue reading

Ninepoint HighShares and CoreShares ETFs Move to Two Distributions Per Month

TORONTO, July 21, 2026 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint”) today announced that its suite of Ninepoint HighShares and Ninepoint CoreShares ETFs will begin paying distributions twice monthly, effective with the August 2026 distribution cycle. Distributions that were previously paid monthly will be divided into two instalments each month, providing investors with more frequent cash flow and a consistent distribution schedule across the suite. “Investors have been clear with us: it’s not just how much a fund distributes, it’s when,” said Karl Cheong, CFA, Executive Vice President, Head of ETFs at Ninepoint Partners. “Investors told us that more frequent cash flow would better align with their investment needs, so we acted on that feedback with a transition to semi-monthly distributions...

Continue reading

 VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Aggregate cash dividend of $17.3 million, or approximately $0.40242 per share NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of VYNE’s common stock at a ratio of 1-for-50 in connection with the anticipated closing of the proposed merger (the “Merger”) with Yarrow Bioscience, Inc. (“Yarrow”). The reverse stock split was previously approved by VYNE’s stockholders at VYNE’s special meeting in lieu of the annual meeting of stockholders held on July 16, 2026 (the “Special Meeting”). Following the Merger, the combined company’s common stock is expected to begin trading on a post-reverse stock split basis on The Nasdaq Capital Market (“Nasdaq”) on July 27, 2026, under the new name “Yarrow Bioscience,...

Continue reading

Aebi Schmidt Group declares quarterly dividend of $0.025 per share and will announce second quarter 2026 earnings on August 13, 2026

FRAUENFELD, Switzerland, July 21, 2026 (GLOBE NEWSWIRE) — Aebi Schmidt Holding AG (NASDAQ: AEBI) (“Aebi Schmidt Group” or the “Company”), a world-class specialty vehicles leader, announced that its Board of Directors declared a quarterly dividend of $0.025 per share, and the Company will hold its second quarter 2026 earnings call and webcast on August 13, 2026.  Declaration of Quarterly Dividend The Company’s Board of Directors declared a quarterly cash dividend of $0.025 per share of common stock (CUSIP: H00501108). The dividend is payable on September 24, 2026 to shareholders of record at the close of business on August 20, 2026. The payment source for the dividend is Switzerland. Under Swiss law, the dividend is a return of capital, fully paid out of reserves from capital contributions and therefore tax free for Swiss shareholders....

Continue reading

Purpose Investments Inc. Announces July 2026 Distributions

TORONTO, July 20, 2026 (GLOBE NEWSWIRE) — Purpose Investments Inc. (“Purpose”) is pleased to announce distributions for the month of July 2026 for its open-end exchange traded funds and closed-end funds (“the Funds”).         The ex-distribution date for all open-end funds is July 29, 2026. The ex-distribution date for all closed-end funds is July 31, 2026.    Open-End Funds Ticker Symbol Distribution per share/unit Record Date Payable Date Distribution FrequencyApple (AAPL) Yield Shares Purpose ETF – ETF Units APLY $0.1667 07/29/2026 08/05/2026 MonthlyPurpose Couche-Tard (ATD) Yield Shares ETF – ETF Series ATDY $0.0650 07/29/2026 08/05/2026 MonthlyPurpose Canadian Financial Income Fund – ETF Series BNC $0.1225¹ 07/29/2026 08/05/2026 MonthlyPurpose Global Bond Fund – ETF Units BND $0.0815 07/29/2026 08/05/2026 MonthlyPurpose...

Continue reading

Monarch Casino & Resort Reports Record Second Quarter 2026 Financial Results

Declares Cash Dividend of $0.30 per Share Payable on September 15, 2026 RENO, Nev., July 20, 2026 (GLOBE NEWSWIRE) — Monarch Casino & Resort, Inc. (Nasdaq: MCRI) (“Monarch” or “the Company”) today reported operating results for the second quarter ended June 30, 2026, as summarized below: ($ in thousands, except per share data and percentages)  Three Months Ended June 30,   Six Months Ended June 30,    2026     2025   Increase     2026     2025   IncreaseNet revenue $142,597   $136,914   4.2 %   $279,147   $262,308   6.4 %                       Net income(1)(2)   32,523     27,008   20.4 %     60,115     46,872   28.3 %                       Adjusted EBITDA(3) $52,999   $51,289   3.3 %   $101,950   $92,420   10.3 %                       Basic EPS $1.82   $1.47   23.8 %   $3.37   $2.55   32.2 %Diluted...

Continue reading

Royalty Pharma declares third quarter 2026 dividend

NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2026 of $0.235 per Class A ordinary share. The dividend will be paid on September 10, 2026, to shareholders of record at the close of business on August 14, 2026. About Royalty Pharma plcFounded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.